Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma

Journal of Cancer - Australia
doi 10.7150/jca.37313
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Rituximab in CD20 Positive Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Expression of Polycomb Targets Predicts Breast Cancer Prognosis

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

Prognostic Value of CD56 Expression in Multiple Myeloma

Research in Oncology
2020English

High Hepsin Expression Predicts Poor Prognosis in Gastric Cancer

Scientific Reports
Multidisciplinary
2016English

CSF Β-Amyloid Predicts Prognosis in Patients With Multiple Sclerosis

Multiple Sclerosis
Neurology
2018English

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma

Journal of Biomedicine and Biotechnology
2012English

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy